Chronic pancreatitis (CP) is a progressive fibroinflammatory process of the pancreas in which the pancreatic secretory parenchyma is damaged and replaced by fibrous tissue, resulting in morphologic changes of the…
Pseudocysts are common lesions of the pancreas that arise from pancreatic ductal disruption. They range from simple, self-resolving cysts to complex, life-threatening cysts that present challenging management decisions. The Atlanta…
Since its introduction, endoscopic retrograde cholangiopancreatography (ERCP) has been an important tool for the confirmation and treatment of acute and chronic pancreatic disease. However, compared with other endoscopic procedures, ERCP…
Autoimmune pancreatitis (AIP) is a unique form of corticosteroid responsive chronic pancreatitis. In recent years, a distinct clinical presentation, histology, serology, and subtypes of AIP have been identified. This rare…
Burden of Acute Pancreatitis in the Modern Era Recent national survey data indicate a rising incidence of acute pancreatitis in the United States, attributed primarily to a rise in biliary…
Jacques Van Dam, MD, PhD, Guest Editor An issue devoted to the modern management of pancreatic disease? Really ? Is there a cure for pancreatic cancer? Well… no. Have we…
Pancreatic ductal adenocarcinoma comprises more than 90% of pancreatic tumors. It is the 10th most common cancer diagnosis in the United States, but represents the fourth most common cause of…
Pancreatic adenocarcinoma is the fourth leading cause of cancer death in the United States, with a 5-year survival rate of 5.6%. One third of pancreatic cancer patients have local or…
Surgical resection remains an important component in the treatment of pancreatic cancer. Unfortunately, only approximately 10% to 20% of patients are eligible for surgical resection at presentation. Many patients with…
Pancreatic adenocarcinoma (PC) is the fourth leading cause of cancer death and is associated with an extremely poor prognosis: The 5-year survival probability is less than 5% for all stages…
